Cargando…
T cell metabolism in graft-versus-host disease
Graft-versus-host disease (GVHD) is a major source of morbidity and mortality following allogeneic hematopoietic stem cell transplant (allo-HSCT), one of the most effective approaches to treat hematopoietic malignancies.(1) However, current prophylaxis regimens and treatments that reduce the detrime...
Autores principales: | Zou, Yujing, Chen, Benny J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974895/ https://www.ncbi.nlm.nih.gov/pubmed/35399863 http://dx.doi.org/10.1097/BS9.0000000000000035 |
Ejemplares similares
-
Targeting Glycolysis in Alloreactive T Cells to Prevent Acute Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia Effect
por: Huang, Ying, et al.
Publicado: (2022) -
T-Cell Metabolism in Graft Versus Host Disease
por: Karl, Franziska, et al.
Publicado: (2021) -
Graft-versus-Host Disease Modulation by Innate T Cells
por: Fang, Ying, et al.
Publicado: (2023) -
Acute graft versus host disease
por: Jacobsohn, David A, et al.
Publicado: (2007) -
Protein dysregulation in graft versus host disease
por: Qian, Liren, et al.
Publicado: (2017)